La Jolla, California
Phase 1 cancer trials in La Jolla, CA
37 Phase 1 cancer studies are recruiting participants at sites in La Jolla as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
La Jolla at a glance
- 37 studies are recruiting at a site in La Jolla.
- By phase: Phase 1 (19), Phase 1/2 (18).
- By sponsor: industry (30), university, hospital or other (4), government (3).
- By research area: Breast Cancer (16), Lung Cancer (8), Lymphoma (5), Prostate Cancer (4), Pancreatic Cancer (3), Melanoma (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in La Jolla
Basic details from each study's public record (the 30 most recently updated of 37). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- UCSD Moores Cancer Center
- Registry record
- NCT06253871 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT06638307 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla
- Registry record
- NCT03424005 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT07029399 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of California, San Diego (UCSD) - Moores Cancer Center
- Registry record
- NCT06400472 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of California, San Diego (UCSD) - Moores Cancer Center
- Registry record
- NCT06465069 · updated
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Study site
- UCSD Moores Cancer Center
- Registry record
- NCT06908928 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT07100106 · updated
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Aminex Therapeutics, Inc.
- Study site
- University of California-San Diego
- Registry record
- NCT07287917 · updated
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Moores Cancer Center
- Registry record
- NCT06997029 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- University of San Diego Moores Cancer Center
- Registry record
- NCT04585750 · updated
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Fate Therapeutics
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT07216105 · updated
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Regor Pharmaceuticals Inc.
- Study site
- University of California, San Diego
- Registry record
- NCT05304962 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in La Jolla
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT06287775 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT06706076 · updated
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Frontier Medicines Corporation
- Study site
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center
- Registry record
- NCT06244771 · updated
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Scripps Clinic Torrey Pines (Scripps Cancer Center) · Scripps Green Hospital · Scripps Shiley Pavilion
- Registry record
- NCT07227298 · updated
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bicara Therapeutics
- Study site
- Moores Cancer Center UC San Diego Health
- Registry record
- NCT04429542 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 9
- Registry record
- NCT07085091 · updated
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- University of California - San Diego Moores Cancer Center
- Registry record
- NCT06343402 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in La Jolla
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07332455 · updated
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Daiichi Sankyo
- Study site
- University of California San Diego Moores Cancer Center
- Registry record
- NCT07244341 · updated
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Acerand Therapeutics (Hong Kong) Limited
- Study site
- University of California San Diego, Moores Cancer Center
- Registry record
- NCT06801236 · updated
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT07545811 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.
Melanoma studies recruiting in La Jolla
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT05896839 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in La Jolla, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in La Jolla
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT06860594 · updated
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- University of California San Diego Medical Center, Moores Cancer Center
- Registry record
- NCT07195916 · updated
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- University of California San Diego (Ucsd) Moores Cancer Center
- Registry record
- NCT05006716 · updated
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06542250 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in La Jolla, CA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in La Jolla
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UC San Diego Moores Cancer Center
- Registry record
- NCT06445062 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in La Jolla, CA on ClinicalTrials.gov.
Ask about studies near La Jolla
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
377 studies recruiting across 44 cities.
Los Angeles
156 studies recruiting.
Duarte
109 studies recruiting.
San Francisco
66 studies recruiting.
Orange
36 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections